|
CN111470998A
|
|
Intermediate for synthesizing camptothecin derivative and preparation method and application thereof
|
|
CN110698378A
|
|
Preparation method of 2- (hydroxy- (methylcyclopropyl) phenylamino) -1-piperazinylacetone derivative
|
|
CN109810085A
|
|
The preparation method of ACC inhibitor and its intermediate
|
|
CN109265408A
|
|
The synthetic method of difluoromethyl substitution oxane -2- ketone
|
|
CN109369631A
|
|
A kind of synthetic method of the key intermediate for synthesizing lactic acid dehydrogenase A inhibitor
|
|
CN108192932A
|
|
A kind of enzymatic preparation method of chiral alcohol
|
|
CN107805274A
|
|
A kind of industrialized preparing process of antibody coupling medicine connexon intermediate
|
|
CN107739387A
|
|
A kind of method for the key intermediate compound for preparing ET-743
|
|
CN106083764A
|
|
A kind of chiral separation method of the high-purity intermediate for preparing AXL inhibitor
|
|
CN106083821A
|
|
A kind of synthetic method of 3,5 two replacement pyrazine 2 benzamide compounds
|
|
CN105669647A
|
|
Synthetic method for intermediate of histone methylase EZH2 inhibitor
|
|
CN105503884A
|
|
Method for synthesizing key intermediate of BET protein inhibitor
|
|
CN111533778A
|
|
Industrial production method of antibody-conjugated drug linker
|
|
CN105111191A
|
|
Key intermediate for synthesis of CDK9 inhibitor, preparation method and application thereof
|
|
CN104974056A
|
|
Chiral resolution method for preparing high-purity intermediate of trabectedin
|
|
CN105017219A
|
|
Synthetic method for p53-MDM2-binding inhibitor dyhydroxyl quinoline derivative
|
|
CN104725324A
|
|
Preparation method of 6-chloromethylpyrimidine-2,4-(1H, 3H)-diketone
|
|
CN104725352A
|
|
Synthesis method and application of 3-(piperidyl-2-yl)-azetidinyl-3-ol derivatives
|
|
CN104830943A
|
|
Preparation method of eldecalcitol intermediate
|
|
CN104711313A
|
|
Preparation method for eldecalcitol intermediate
|
